1/2
Read More
A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agencyâs decision to approve Biogen Incâs (BIIB.O) Alzheimerâs disease treatment despite the committeeâs recommendation against doing so.
Aaron Kesselheim, a Professor of Medicine at Harvard Medical School who had served on the FDAâs advisory committee for nervous system drugs since 2015, told Reuters on Thursday he was stepping down from the panel. My rationale was that the FDA needs to re-evaluate how it solicits and uses the advisory committees . because I didnât think that the firm recommendations from the committee in this case . were appropriately integrated into the decision-making process, Kesselheim said in an email.
89bio Initiates Phase 2b ENLIVEN Trial of BIO89-100 for the Treatment of NASH streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BOSTON – In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration,.
1:33 PM UTC
share-square-1246517
BOSTON, MA – The Red Sox today announced that Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, MD, MPH, will be throwing out the ceremonial first pitch on Saturday, May 29, before the 4:10 p.m. game against the Miami Marlins. Saturday’s game marks the lifting of restrictions and capacity limitations in the Commonwealth of Massachusetts and at Fenway Park, allowing for the opportunity to operate the ballpark at full capacity.
Dr. Walensky is the 19th Director of the CDC and the ninth Administrator of the Agency for Toxic Substances and Disease Registry. Prior to her current role, Dr. Walensky served as Chief of the Division of Infectious Diseases at Massachusetts General Hospital from 2017-2020 and Professor of Medicine at Harvard Medical School from 2012-2020. She served on the frontline of the COVID-19 pandemic and conducted research on vaccine delivery and strategies to reach underserved communities.